Skip to main content
2026 CRT Conference Main banner

CRT 2026

Spotlight

Session:: Spotlight Session | Complex Coronary Symposium: CRT and DCB Academy Joint Session [Non-CME]

COMPLEX CORONARY SYMPOSIUM

Monday, March 9, 2026
2:00 PM - 3:58 PM EST
Location: Spotlight Theater

    Moderator(s)

  • Jeffrey W. Moses, MD, FSCAI

    John and Myrna Daniels Professor of Cardiology
    Columbia University Medical Center
    New York, New York, United States

    Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)

  • Bernardo Cortese, MD, FESC, FSCAI

    Director of Coronary Program
    University Hospitals
    Cleveland, Ohio, United States

    Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

    • Panel Discussant(s)

  • Gheorghe Doros, PhD, MBA

    Director of Statistical consulting
    Baim Institute for Clinical Research; Boston University
    Boston, Massachusetts, United States

    Disclosure(s): No financial relationships to disclose

  • Tanveer Rab, MD, FACC, MSCAI

    Emeritus Professor
    Emory University
    Brookhaven, Georgia, United States

    Disclosure(s): No financial relationships to disclose

  • Tarek Helmy, MD, FACC, MSCAI

    Regional Chairman of the Cardiovascular Service Line
    Trinity Health of New England
    West Hartford, Connecticut, United States

    Disclosure(s): Medtronic: proctor for TAVR (Ongoing)

Disclosure(s):
Jeffrey W. Moses, MD, FSCAI: Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
Bernardo Cortese, MD, FESC, FSCAI: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Gheorghe Doros, PhD, MBA: No financial relationships to disclose
Tanveer Rab, MD, FACC, MSCAI: No financial relationships to disclose
Tarek Helmy, MD, FACC, MSCAI: Medtronic: proctor for TAVR (Ongoing)